Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

5. Accounts Receivable

12 Months Ended

Mar. 31, 2021

NOTE 5 – Accounts Receivable

Accounts receivable, net consists of the following:

	March 31,
	2021			2020
Accounts receivable	$	4,419,000		$	6,231,000
Less: allowance for doubtful accounts		(125,000	)		(1,028,000	)
Less: discounts, rebates, distributor fees and returns		(1,488,000	)		(1,230,000	)
	$	2,806,000		$	3,973,000